InvestorsHub Logo
Followers 2
Posts 307
Boards Moderated 0
Alias Born 09/22/2006

Re: MDtoB22 post# 30291

Sunday, 07/19/2020 12:24:36 PM

Sunday, July 19, 2020 12:24:36 PM

Post# of 34625
No, I dont think so, and thinking, correctly or incorrectly, is all we have..
TPIV 100,110,200 was last updated July, a year ago, and now 3 years from 2017 when they did report very favorable pre clinic and phase 1\2 results... those of us in then were so encouraged, that an additional medical tool was about to be available with DoD funding, fast track, and orphan status granting... then we asked, what more could you want in a company... then with P.H. all went dark, and we became discouraged during the three years. Pumpers and loyalists have faded into the night.
The combined Marker, with new and additional promise still remains behind the big dark curtain. Only the stage crew has any insight. I could blather on, but I would ask... regarding the 48,000 now leased building and set up as operational in 2021, with haste, what are the plans for its use.. our clinical production or for third party availability? We deserve to know. Or, have certain things happened including research protection at Baylor that propriety use had to take place?
Don't you think a well worded disclosure is appropriate?
The FDA lifted its hold. COVID has not stopped other bio science public companies.. come on, what DO you think?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News